U.S. markets closed

Smith & Nephew plc (SNN)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
31.98+0.43 (+1.36%)
At close: 04:00PM EDT
31.98 -0.01 (-0.03%)
After hours: 04:10PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Price Crosses Moving Average

Price Crosses Moving Average

Previous Close31.55
Bid28.25 x 800
Ask39.01 x 800
Day's Range31.49 - 32.01
52 Week Range29.40 - 44.47
Avg. Volume938,590
Market Cap13.949B
Beta (5Y Monthly)0.38
PE Ratio (TTM)26.78
EPS (TTM)1.19
Earnings DateN/A
Forward Dividend & Yield0.75 (2.35%)
Ex-Dividend DateMar 31, 2022
1y Target Est38.47
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
Near Fair Value
9% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for SNN

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Smith & Nephew SNATS, Inc.
    Analyst Report: Smith & Nephew plcSmith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
    Fair Value
    Economic Moat
    23 days agoMorningstar
View more